Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial

被引:0
作者
Wolisnky, J. S. [1 ]
Brochet, B. [2 ]
Montalban, X. [3 ,4 ]
Naismith, R. T. [5 ]
Manfrini, M. [6 ]
Garas, M. [6 ]
Villoslada, P. [7 ]
Model, F. [6 ]
Hubeaux, S. [6 ]
Kappos, L. [8 ]
Hauser, S. L. [9 ]
机构
[1] UTHealth, McGovern Med Sch, Houston, TX USA
[2] Univ Bordeaux, Bordeaux, France
[3] Univ Toronto, Div Neurol, Toronto, ON, Canada
[4] Vall dHebron Univ Hosp, Barcelona, Spain
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] F Hoffmann La Roche Ltd, Basel, Switzerland
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] Univ Basel, Univ Hosp Basel, Basel, Switzerland
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
基金
新加坡国家研究基金会;
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P910
引用
收藏
页码:490 / 491
页数:2
相关论文
共 50 条
[41]   Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial [J].
Palumbo, Antonio ;
Cavo, Michele ;
Bringhen, Sara ;
Zamagni, Elena ;
Romano, Alessandra ;
Patriarca, Francesca ;
Rossi, Davide ;
Gentilini, Fabiana ;
Crippa, Claudia ;
Galli, Monica ;
Nozzoli, Chiara ;
Ria, Roberto ;
Marasca, Roberto ;
Montefusco, Vittorio ;
Baldini, Luca ;
Elice, Francesca ;
Callea, Vincenzo ;
Pulini, Stefano ;
Carella, Angelo M. ;
Zambello, Renato ;
Benevolo, Giulia ;
Magarotto, Valeria ;
Tacchetti, Paola ;
Pescosta, Norbert ;
Cellini, Claudia ;
Polloni, Claudia ;
Evangelista, Andrea ;
Caravita, Tommaso ;
Morabito, Fortunato ;
Offidani, Massimo ;
Tosi, Patrizia ;
Boccadoro, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) :986-993
[42]   Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study [J].
Genchi, Angela ;
Brambilla, Elena ;
Sangalli, Francesca ;
Radaelli, Marta ;
Bacigaluppi, Marco ;
Furlan, Roberto ;
Andolfo, Annapaola ;
Drago, Denise ;
Magagnotti, Cinzia ;
Scotti, Giulia Maria ;
Greco, Raffaella ;
Vezzulli, Paolo ;
Ottoboni, Linda ;
Bonopane, Marco ;
Capilupo, Daniela ;
Ruffini, Francesca ;
Belotti, Daniela ;
Cabiati, Benedetta ;
Cesana, Stefania ;
Matera, Giada ;
Leocani, Letizia ;
Martinelli, Vittorio ;
Moiola, Lucia ;
Vago, Luca ;
Panina-Bordignon, Paola ;
Falini, Andrea ;
Ciceri, Fabio ;
Uglietti, Anna ;
Sormani, Maria Pia ;
Comi, Giancarlo ;
Battaglia, Mario Alberto ;
Rocca, Maria A. A. ;
Storelli, Loredana ;
Pagani, Elisabetta ;
Gaipa, Giuseppe ;
Martino, Gianvito .
NATURE MEDICINE, 2023, 29 (01) :75-+
[43]   Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study [J].
Angela Genchi ;
Elena Brambilla ;
Francesca Sangalli ;
Marta Radaelli ;
Marco Bacigaluppi ;
Roberto Furlan ;
Annapaola Andolfo ;
Denise Drago ;
Cinzia Magagnotti ;
Giulia Maria Scotti ;
Raffaella Greco ;
Paolo Vezzulli ;
Linda Ottoboni ;
Marco Bonopane ;
Daniela Capilupo ;
Francesca Ruffini ;
Daniela Belotti ;
Benedetta Cabiati ;
Stefania Cesana ;
Giada Matera ;
Letizia Leocani ;
Vittorio Martinelli ;
Lucia Moiola ;
Luca Vago ;
Paola Panina-Bordignon ;
Andrea Falini ;
Fabio Ciceri ;
Anna Uglietti ;
Maria Pia Sormani ;
Giancarlo Comi ;
Mario Alberto Battaglia ;
Maria A. Rocca ;
Loredana Storelli ;
Elisabetta Pagani ;
Giuseppe Gaipa ;
Gianvito Martino .
Nature Medicine, 2023, 29 :75-85
[44]   Safety patterns with ozanimod in phase 3 and open-label extension trials in patients with relapsing multiple sclerosis [J].
Selmaj, K. W. ;
Ziemssen, T. ;
Comi, G. ;
Hartung, H. P. ;
Singal, M. ;
Thorpe, A. ;
Riolo, J. V. ;
Cheng, C. Y. ;
Sheffield, J. K. ;
Krakovich, A. ;
Vermersch, P. ;
Cree, B. A. C. .
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 :324-324
[45]   An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia [J].
Murakami, Masato ;
Osada, Kenichi ;
Ichibayashi, Hisao ;
Mizuno, Hiromichi ;
Ochiai, Toshimitsu ;
Ishida, Mitsuhiro ;
Alev, Levent ;
Nishioka, Kusuki .
MODERN RHEUMATOLOGY, 2017, 27 (04) :688-695
[46]   Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis [J].
Giovannoni, G. ;
Kappos, L. ;
Hauser, S. L. ;
Montalban, X. ;
Koendgen, H. ;
Prajapati, K. ;
Manfrini, M. ;
Mehta, L. ;
Wolinsky, J. S. .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 :537-538
[47]   Long-term reduction of relapse rate and confirmed disability progression after 6 years of ocrelizumab treatment in patients with relapsing multiple sclerosis [J].
Giovannoni, G. ;
Kappos, L. ;
Hauser, S. L. ;
Montalban, X. ;
Koendgen, H. ;
Prajapati, K. ;
Manfrini, M. ;
Mehta, L. ;
Wolinsky, J. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[48]   Infusion-related reactions in the Phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis (PPMS) [J].
Montalban, X. ;
Arnold, D. ;
Bar-or, A. ;
de Seze, J. ;
Giovannoni, G. ;
Hemmer, B. ;
Rammohan, K. ;
Mairon, N. ;
Chin, P. ;
Fontoura, P. ;
Garren, H. ;
Masterman, D. ;
Sauter, A. ;
Wolinsky, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 :410-410
[49]   Long-term reduction of relapse rate and confirmed disability progression after 5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis [J].
Hauser, S. L. ;
Brochet, B. ;
Montalban, X. ;
Naismith, R. T. ;
Wolinsky, J. S. ;
Manfrini, M. ;
Garas, M. ;
Villoslada, P. ;
Model, F. ;
Hubeaux, S. ;
Kappos, L. .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 :285-286
[50]   ABATACEPT TREATMENT FOR PATIENTS WITH EARLY ACTIVE PRIMARY SJOGREN'S SYNDROME: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL [J].
Arends, S. ;
Van Nimwegen, J. F. ;
Mossel, E. ;
Van Zuiden, G. S. ;
Delli, K. ;
Stel, A. J. ;
Van der Vegt, B. ;
Haacke, E. A. ;
Olie, L. ;
Los, L. ;
Verstappen, G. M. ;
Pringle, S. A. ;
Spijkervet, F. K. L. ;
Kroese, F. G. M. ;
Vissink, A. ;
Bootsma, H. .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :102-102